L Moureau-Zabotto

Summary

Affiliation: Institut Paoli-Calmettes
Country: France

Publications

  1. pmc Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review
    Simon G Launay
    Department of Medical Oncology, Institut Paoli Calmettes, 232 Bd Ste Marguerite, Marseille, 13009, France
    BMC Cancer 11:423. 2011
  2. pmc Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature
    Cécile Cauvin
    Department of Radiotherapy, Institut Paoli Calmettes, 27 Bd Lei Roure, 13009, Marseille, France
    BMC Cancer 11:323. 2011
  3. ncbi request reprint Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer
    L Moureau-Zabotto
    service d oncologie radiothérapie, Universite Paris, France
    Breast Cancer Res Treat 91:61-71. 2005
  4. doi request reprint Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en O
    Laurence Moureau-Zabotto
    Hopital Tenon, Service de Radiotherapie, 4 rue de la Chine, 75020 Paris, France
    J Clin Oncol 26:1080-5. 2008
  5. doi request reprint Is neoadjuvant chemotherapy prior to radio-chemotherapy beneficial in T4 anal carcinoma?
    L Moureau-Zabotto
    Radiation Oncology Department, Institut Paoli Calmettes, Marseille, France
    J Surg Oncol 104:66-71. 2011
  6. ncbi request reprint [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]
    L Moureau-Zabotto
    service d oncologie radiothérapie, Hopital Tenon, 4, rue de la Chine, 75020 Paris, France
    Cancer Radiother 9:575-86. 2005
  7. ncbi request reprint [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion]
    D Lerouge
    service d oncologie radiothérapie, Hopital Tenon, AP HP, 75020 Paris Cedex 20, France
    Cancer Radiother 8:168-77. 2004
  8. doi request reprint Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response
    O Turrini
    Department of Surgical Oncology, Institut Paoli Calmettes and Université de la Mediterranée, Marseille, France
    Eur J Surg Oncol 36:987-92. 2010
  9. ncbi request reprint [Radiotherapy of carcinomas of the anal canal. Tenon Hospital experience]
    E Touboul
    service d oncologie radiothérapie, Hopital Tenon, AP HP, 4, rue de la Chine, 75020 Paris, France
    Cancer Radiother 7:91s-99s. 2003
  10. doi request reprint [Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival]
    B Farnault
    Departement de Radiotherapie, Institut Paoli Calmettes, 232, boulevard Sainte Marguerite, 13009 Marseille, France
    Cancer Radiother 15:279-86. 2011

Collaborators

Detail Information

Publications17

  1. pmc Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review
    Simon G Launay
    Department of Medical Oncology, Institut Paoli Calmettes, 232 Bd Ste Marguerite, Marseille, 13009, France
    BMC Cancer 11:423. 2011
    ..They are characterized by slow growth and long history with frequent local relapses, and sometimes metastases. While chemotherapy is not efficient, imatinib has shown antitumor activity...
  2. pmc Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature
    Cécile Cauvin
    Department of Radiotherapy, Institut Paoli Calmettes, 27 Bd Lei Roure, 13009, Marseille, France
    BMC Cancer 11:323. 2011
    ..Primary leiomyosarcoma of the seminal vesicle is exceedingly rare...
  3. ncbi request reprint Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer
    L Moureau-Zabotto
    service d oncologie radiothérapie, Universite Paris, France
    Breast Cancer Res Treat 91:61-71. 2005
    ..To assess the significance of S-phase fraction (SPF) and DNA ploidy evaluated by DNA flow cytometry as prognostic markers in stage I or II breast cancer...
  4. doi request reprint Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en O
    Laurence Moureau-Zabotto
    Hopital Tenon, Service de Radiotherapie, 4 rue de la Chine, 75020 Paris, France
    J Clin Oncol 26:1080-5. 2008
    ....
  5. doi request reprint Is neoadjuvant chemotherapy prior to radio-chemotherapy beneficial in T4 anal carcinoma?
    L Moureau-Zabotto
    Radiation Oncology Department, Institut Paoli Calmettes, Marseille, France
    J Surg Oncol 104:66-71. 2011
    ..This study retrospectively describes the outcome of a series of 38 patients (pts) with T4 anal carcinoma exclusively treated by radio and chemotherapy...
  6. ncbi request reprint [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]
    L Moureau-Zabotto
    service d oncologie radiothérapie, Hopital Tenon, 4, rue de la Chine, 75020 Paris, France
    Cancer Radiother 9:575-86. 2005
    ..To assess the significance of S-phase fraction (SPF) and DNA ploidy evaluated by DNA flow cytometry as prognostic markers in stage I or II breast cancer...
  7. ncbi request reprint [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion]
    D Lerouge
    service d oncologie radiothérapie, Hopital Tenon, AP HP, 75020 Paris Cedex 20, France
    Cancer Radiother 8:168-77. 2004
    ..To evaluate preliminary results in terms of toxicity, local tumour control, and survival after preoperative concomitant chemoradiation for operable bulky cervical carcinomas...
  8. doi request reprint Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response
    O Turrini
    Department of Surgical Oncology, Institut Paoli Calmettes and Université de la Mediterranée, Marseille, France
    Eur J Surg Oncol 36:987-92. 2010
    ..To assess the safety and efficacy of a new neoadjuvant chemoradiation (CRT) docetaxel-based regimen in patients with resectable adenocarcinoma of the pancreatic head or body...
  9. ncbi request reprint [Radiotherapy of carcinomas of the anal canal. Tenon Hospital experience]
    E Touboul
    service d oncologie radiothérapie, Hopital Tenon, AP HP, 4, rue de la Chine, 75020 Paris, France
    Cancer Radiother 7:91s-99s. 2003
    ..We report the Tenon hospital experience since 1972 concerning the long term results after radiation therapy, the modifications of the radiation technique, and the evolution of treatment strategy...
  10. doi request reprint [Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival]
    B Farnault
    Departement de Radiotherapie, Institut Paoli Calmettes, 232, boulevard Sainte Marguerite, 13009 Marseille, France
    Cancer Radiother 15:279-86. 2011
    ..The aim of this study was to correlate tumour response to survival and to identify predictive factors for tumour response after chemoradiation...
  11. ncbi request reprint [Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases]
    E Deniaud-Alexandre
    service d oncologie radiothérapie, Hopital Tenon AP HP, 4, rue de la Chine, 75020 Paris, France
    Cancer Radiother 8:95-107. 2004
    ..To identify predicting factors of local control and survival after isolate local failure by statistical analysis of the data after breast-conserving treatment for early breast cancer...
  12. pmc Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients
    L Moureau-Zabotto
    service d oncologie radiothérapie, Hopital Tenon, AP HP, CancerEst, GHU Est, Universite Paris VI, 4 rue de la Chine, Paris 75020, France
    Br J Cancer 94:473-80. 2006
    ..The levels of MDR1 and MRP1 expression had no significant influence on DFS or OS. GSTP1 expression can be considered to be an independent prognostic factor for DFS in patients receiving adjuvant chemotherapy for breast cancer...
  13. ncbi request reprint [The impact of integrating images of positron emission tomography with computed tomography simulation on radiation therapy planning]
    E Touboul
    service d oncologie radiothérapie, Hopital Tenon AP HP, CancerEst, Universite Paris VI, GHU Est, 4, rue de la Chine, 75020 Paris, France
    Cancer Radiother 8:S29-35. 2004
    ..The impact on treatment outcome remains to be demonstrated...
  14. ncbi request reprint [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients]
    D Lerouge
    service d oncologie radiothérapie, Hopital Tenon AP HP, 4, rue de la Chine, 75020 Paris, France
    Cancer Radiother 8:155-67. 2004
    ..To evaluate our updated data concerning survival and locoregional control in a study of locally advanced non inflammatory breast cancer after primary chemotherapy followed by external preoperative irradiation...
  15. doi request reprint Management and clinical outcome of rectal cancer in patients ≥ 80 years treated in southern France (PACA region) between 2006 and 2008
    L Moureau-Zabotto
    Departement de Radiotherapie, Institut Paoli Calmettes, France
    J Surg Oncol 108:450-6. 2013
    ..Their clinical history and outcome after treatment are poorly described. This retrospective study was undertaken to provide more data and to compare therapeutic strategies to the standard of care for younger patients...
  16. ncbi request reprint [Impact of computed tomography (CT) and 18F-deoxyglucose positron emission tomography (FDG-PET) image fusion for conformal radiotherapy in esophageal carcinoma]
    L Moureau-Zabotto
    service d oncologie radiothérapie, Hopital Tenon AP HP, 4, rue de la Chine, 75020 Paris et CancerEst, Universite Paris VI, GHU Est, France
    Cancer Radiother 9:152-60. 2005
    ..To study the impact of fused (18)F-fluoro-deoxy-D-glucose (FDG)-hybrid positron emission tomography (PET) and computed tomography (CT) images on conformal radiation therapy (CRT) planning for patients with esophageal carcinoma...
  17. doi request reprint BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
    A Goncalves
    Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France
    Ann Oncol 23:2799-805. 2012
    ..The BAYPAN study was a multicentric, placebo-controlled, double-blind, randomized phase III trial comparing gemcitabine/sorafenib and gemcitabine/placebo in the treatment of APC...